Abstract:Objective This article is intended to make a study on the expressive levels of mucin core proteins (MUC1 and MUC5AC) and detect their clinicopathologic significances in the benign and malignant lesions of gallbladder.Methods: EnVision immunohistochemical method for determining the expressions of MUC1 and MUC5AC was used in routinely paraffin-embedded sections of surgically resected specimens from gallbladder adenocarcinoma (n = 108), peritumoral tissues (n 46), adenoma (n 15), and chronic cholecystitis (n 35).Results: The positive rate of MUC1 expression was significantly higher in gallbladder adenocarcinoma than that in peritumoral tissues (chi(2) = 16.49, P < 0.01), adenoma (chi(2) = 7.40, P < 0.01), and chronic cholecystitis (chi(2) = 28.57, P < 0.01), while the positive rate of MUC5AC expression was significantly lower in gallbladder adenocarcinoma than that in peritumoral tissues (chi(2) = 12.83, P < 0.01), adenoma (chi(2) = 4.22, P < 0.05), and chronic cholecystitis (chi(2) = 20.25, P < 0.01). The positive cases of MUC1 and the negative ones of MUC5AC in the benign lesions showed moderate-or severe-dysplasia of gallbladder epithelium. The positive rates of MUC1 were significantly lower in gallbladder adenocarcinomas with maximal diameter of mass <2 cm, no metastasis of lymph node, and no invasiveness of regional tissues (P < 0.05 or P < 0.01) than those in gallbladder adenocarcinomas with maximal diameter of mass >2 cm, metastasis of lymph node, and invasiveness of regional tissues (P < 0.05 or P < 0.01). However, the positive rates of MUC5AC were significantly higher in the highly differentiated adenocarcinoma with maximal diameter of mass <2 cm than those in the low-differentiated adenocarcinoma with maximal diameter of mass >= 2 cm. Univariate Kaplan-Meier analysis showed that increased expression of MUC1 (P = 0.064) or decreased expression of MUC5AC (P = 0.017) was associated with decreased overall survival. Multivariate Cox regression analysis showed that decreased expression of MUC5AC (P = 0.008) was an independent prognostic predictor to gallbladder adenocarcinoma.Conclusions: The expression of MUC1 and MUC5AC might be closely related to the carcinogenesis, clinical biological behaviors, and prognosis of gallbladder adenocarcinoma. J. Surg. Oncol. 2012;105:97-103. (C) 2011 Wiley Periodicals, Inc.

Expression Differences of Cathepsin B and Cathepsin D in Primary Gallbladder Cancer, Gallbladder Adenomatous Polyps and Chronic Cholecystitis

Significance of Cathepsin D and Chromogranin A Expression in Human Primary Hepatocellular Carcinomas

Expressions and clinical significance of Cyr61 andβ-catenin in gallbladder carcinoma

The Expression of E-cadherin, Α- or Β-Catenin in Gallbladder Carcinoma and Cholangiocarcinoma and Implication

Expression and significance of LC3 and cathepsin D in human endometrioid adenocarcinoma.

Expression of Β-Catenin and Cyclind1 in Biliary Tumors and Its Clinical Significance

Expressions of Cath-D and MMP-9 Associated with Recurrence Metastasis and Prognosis of Bladder Transitional Cell Carcinoma

[Cathepsin B Expression and Its Significance in Non-Small Cell Lung Cancer Tissues].

Expression and Clinicopathologic Significance of Cathepsin D in Breast Cancer

Clinicopathologic Significance of Minichromosome Maintenance Protein 2 and Tat-interacting Protein 30 Expression in Benign and Malignant Lesions of the Gallbladder

Expressions of GRP78 and GRP94 in the benign and malignant lesions of gallbladder and their clinicopathological significance

Study on the expression of GSCs marker and it′s regulated factor in benign and malignant gallbladder lesions

Expression of Cdx2 and Hepatocyte Antigen in Benign and Malignant Lesions of Gallbladder and Its Correlation with Histopathologic Type and Clinical Outcome

Expressive Levels of Muc1 and Muc5ac and Their Clinicopathologic Significances in the Benign and Malignant Lesions of Gallbladder

The Expressions of Cathepsin D and Type Ⅳ Collagen and Their Significance in Human Bladder Carcinoma

EphA10 and EphB3 Are Prognostic Markers in Gallbladder Squamous Cell/adenosquamous Carcinomas and Adenocarcinomas.

Expression of CCL3 and its receptor CCR1 in gallbladder adenocarcinoma and its benign lesions and its clinico-pathological significance

Expressions and Clinical Significance of TGF-β1, MMP-2 in Gallbladder Carcinoma

Expressive Levels of MUC1 and MUC5AC and Its Clinicopathological Significances in Benign and Malignant Lesions of Gallbladder

Expression and Clinical Significance of Chitinase-3-1ike Protein 1 in Gallbladder Cancer

Expressions and Clinicopathologic Significances of CA19-9 and CA125 in Benign and Malignant Lesions of Gallbladder